Scientific Publications
SphingoTec's biomarker discovery is based on the highest standard of evidence, with over 100 publications, over 100 clinical studies, and more than 100.000 patients enrolled. Browse our scientific publications to learn more about how our biomarkers can impact patient care. You can use filters to narrow your search results by Year, Biomarker and Indications.
Filter
Results
2022
bio-ADM
Sepsis
Other
2022
DPP3
Cardiovascular Disease
Sepsis
Other
2022
bio-ADM
penKid
Sepsis
Other
2022
DPP3
Cardiogenic Shock
Sepsis
Other
2022
bio-ADM
Sepsis
Other
2022
penKid
Acute Kidney Injury
Sepsis
Other
2020
penKid
Acute Kidney Injury
Sepsis
2020
bio-ADM
penKid
Acute Kidney Injury
Sepsis